25 nov. 2024
LSL PHARMA GROUP ANNOUNCES STRONG FISCAL Q3-24 RESULTS AND $2.4 MILLION DEBT FINANCINGS TO SUPPORT ITS GROWTH INITIATIVES
LSL Pharma Group announces its fiscal Q3-24 results
Groupe LSL Pharma annonce ses résultats financiers du Q3-24
6 nov. 2024
New International clients and Production Capacity increase for Steri-Med
